透過您的圖書館登入
IP:100.26.196.222
  • Journals
  • OpenAccess

Stem Cell-Derivative Improves Parkinson's Disease

Abstracts


Five years ago, a 63-year-old woman was diagnosed with Parkinson's disease (PD) with right upper limb tremor. Right lower limb tremor was noted in the last 2 years. Drugs, including a monoamine oxidase type B (MAO-B) inhibitor, an anticholinergic agent, and amantadine, were administered for 3 years, but the patient's improvement was limited. TELOXOME, a novel stem cell-derived agent produced by ContiNew Medical, was intravenously infused weekly. Subsequently, lower limb tremor disappeared and upper limb tremor also diminished after the treatment with 4 doses of TELOXOME. The patient's levels of plasma Cyfra21-1, lactate dehydrogenase (LDH), and tumor necrosis factor-α (TNF-α) were high before treatment but returned to the normal range after 4 infusions.

Keywords

TELOXOME

Read-around